To date, the Accelerator Loan Program has awarded $18.7 million to twenty eight companies, which have generated more than $150 million in additional equity or acquisition proceeds. Six of these companies -- Good Start Genetics, InVivo Therapeutics, 4s3 Bioscience, Pluromed, MoMelan and Avaxia Biologics -- have paid back their Accelerator loans early with interest. Excellims Corporation is a biotechnology company that designs, manufactures and sells High Performance Ion Mobility Spectrometers (HPIMS) that bring the advantages of speed, resolution, sensitivity and field robustness to analytical applications in life sciences. Funding from the MLSC will be used for working capital and commercialization efforts, including the building of 4 HPIMS instruments for customer demonstrations, adding to the management team, and hiring sales and scientific staff.